M160T (p.Met160Thr) variant of TRAF6 (TNF receptor-associated factor 6)

M160T (p.Met160Thr) in TRAF6 (TNF receptor-associated factor 6) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of TRAF6-related disorder. The available variant effect predictions contribute to a CATVariant prioritization score of 0.18 / 1. The record also includes population frequency data and structural context.

M160T (p.Met160Thr) variant details